Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders - PubMed (original) (raw)

Review

. 2009 May;23(5):597-602.

doi: 10.1002/ptr.2625.

Affiliations

Review

Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders

Caterina Scuderi et al. Phytother Res. 2009 May.

Abstract

Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis sativa. It displays a plethora of actions including anticonvulsive, sedative, hypnotic, antipsychotic, antiinflammatory and neuroprotective properties. However, it is well established that CBD produces its biological effects without exerting significant intrinsic activity upon cannabinoid receptors. For this reason, CBD lacks the unwanted psychotropic effects characteristic of marijuana derivatives, so representing one of the bioactive constituents of Cannabis sativa with the highest potential for therapeutic use.The present review reports the pharmacological profile of CBD and summarizes results from preclinical and clinical studies utilizing CBD, alone or in combination with other phytocannabinoids, for the treatment of a number of CNS disorders.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources